Middle-Aged Americans & Dementia Risk: Lots of Worry, Not Enough Proven Prevention

Nearly half of 50- to 64-year-olds think they’re likely to develop Alzheimer’s disease or another form of dementia, but few have talked to a doctor about what they can do to reduce their risk, and many use unproven tactics.

4:00 PM

Author | Kara Gavin

Man writing on paper

 

Nearly half of Americans in their 50s and early 60s think they're likely to develop dementia as they grow older, but only 5% of them have actually talked with a doctor about what they could do to reduce their risk, a new study finds.

Meanwhile, a third or more say they're trying to stave off dementia by taking supplements or doing crossword puzzles – despite the lack of proof that such tactics work.

The new findings suggest a need for better counseling for middle-aged Americans about the steps they can take to keep their brains healthy as they age.

Meanwhile, pharmaceutical companies continue to work on potential dementia-preventing medications. But an over-estimation of future dementia risk by individuals may lead to costly over-use of such products, the researchers warn.

The new results appear in a research letter in the new edition of JAMA Neurology, and a presentation at the Gerontological Society of America's annual meeting.

Both are by members of a team from the University of Michigan's Institute for Healthcare Policy and Innovation who analyzed data from a nationally representative poll of 1,019 adults between the ages of 50 and 64.

Donovan Maust, M.D., M.S., a geriatric psychiatrist specializing in dementia-related care and lead author of the JAMA Neurology letter, notes that even among the oldest Americans, the risk of dementia is lower than one in three people over age 85.

Risk starts rising around age 65 and is higher among people of Latino or African-American heritage.

When people are in their 50s and early 60s, he says, they still have time to bring down their future dementia risk.

"There is growing evidence that adults in mid-life can take steps to lower their risk of dementia, including increasing physical activity and controlling health conditions like hypertension and diabetes," says Maust. "Unfortunately, our findings suggest that people may not be aware of this and are not asking their doctor."

Meanwhile, the new study shows 32% of those polled said they were taking fish oil or omega-3 fatty acid supplements and 39% said they took other supplements for brain health. More than half said they were doing crossword puzzles or other brain games in hopes of keeping their minds "sharp."

Other findings

The new data come from the National Poll on Healthy Aging, carried out by IHPI with support from AARP and Michigan Medicine, U-M's academic medical center. The new paper, and GSA presentation by poll co-director Erica Solway, Ph.D., M.S.W., delve deeper into the poll data than the report issued earlier this year.

The level of worry about dementia among some groups of middle-aged adults may not be in line with their risk compared to others, the study suggests.

For example, studies suggest that people of Latino heritage are about 50% more likely to develop dementia than non-Latino whites, and African-Americans are about twice as likely as non-Latino whites.

However, in the poll, those of African-American or Latino backgrounds didn't consider themselves more likely to develop dementia than white respondents. In fact, African-American respondents felt they were significantly less likely to develop dementia than other groups.

There is growing evidence that adults in mid-life can take steps to lower their risk of dementia. Unfortunately, our findings suggest that people may not be aware of this and are not asking their doctor.
Donovan Maust, M.D., M.S.

Similarly, middle-aged people with worse physical health because of conditions such as diabetes, high blood pressure and heart disease are more likely to develop dementia than those in good health. However, poll respondents who reported their physical health as just fair or poor didn't judge their risk of dementia to be higher than their healthier peers.

Turning worry into prevention

Reducing the risk of developing dementia can be done in mid-life through things like increasing physical activity, smoking cessation and managing chronic medical conditions such as diabetes or hypertension, says Maust.

Physicians and public health authorities should communicate to middle-aged adults that taking these steps are the most evidence-based strategies to help preserve brain function into old age, Maust says, as well as reducing the risk of everything from heart attacks and strokes to lung disease, cancer, loss of vision and mobility.

Even if drug developers succeed where past attempts have failed, and come up with medications that act specifically to prevent dementia, those drugs are likely to be costly. And the failure of several would-be preventive drugs mean it could be years before one hits the market. 

But people in their 50s and 60s can take specific actions to improve their health now at much lower cost to themselves and society, plus saving the dollars they've been spending on supplements and brain games.

In addition to Maust and Solway, the authors of the paper and presentation are IHPI members and U-M faculty Kenneth M. Langa, M.D., Ph.D., Jeffrey Kullgren, M.D., M.S., M.P.H. and NPHA director Preeti Malani, MD, MSJ, and poll team members Matthias Kirch, M.S. and Dianne C. Singer, M.P.H.

The National Poll on Healthy Aging results behind the paper and presentation are based on responses from a nationally representative sample of 1,019 adults aged 50 to 64 who answered a wide range of questions online. Questions were written, and data interpreted and compiled, by the IHPI team. Laptops and Internet access were provided to poll respondents who did not already have them. A previous report of the initial findings and poll methodology is available at www.healthyagingpoll.org, along with past National Poll on Healthy Aging reports. 

Paper cited: "Perception of Dementia Risk and Preventive Actions Among US Adults Aged 50 to 64 Years," JAMA Neurology. DOI: 10.1001/jamaneurol.2019.3946


More Articles About:

Rounds Alzheimer's Disease Wellness and Prevention Alternative Medicine Neurological (Brain) Conditions
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Health Lab

Despite Worry, Older Americans Don’t Ask Doctors About Dementia

Many people in their 50s and early 60s buy supplements or do puzzles in hopes of staving off memory loss and dementia. But without mentioning their concern to health providers, they may miss out on proven strategies that protect brain health.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.
Graphic of parents stressed about bills
Health Lab

4 in 5 parents say having a baby is too expensive

Four in five parents say it costs too much to have a baby, according to the University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health.
Minding memory above a microphone on a blue background
Minding Memory

Can Your Voice Reveal Early Signs of Alzheimer’s?

In this episode, Lauren & Matt speak with Neguine Rezaii, MD, an Assistant Professor of Neurology at Harvard Medical School and a Board-Certified Neuropsychiatrist at Mass General Hospital. Dr. Rezaii’s research focuses on using natural language processing and artificial intelligence to improve the detection and classification of neurodegenerative disorders. Dr. Rezaii talks about her recent study, “Voiceprints of Cognitive Impairment: Analyzing Digital Voice for Early Detection of Alzheimer’s and Related Dementias,” which explores how artificial intelligence can analyze short speech samples to identify subtle signs of cognitive impairment. The study used speech recordings from 120 individuals and found that features such as pauses, word choice and the specificity of language can help distinguish cognitive impairment and Alzheimer’s disease. The conversation also explores how a simple 30-second speech test could potentially be used in clinical settings to support earlier detection and monitoring of cognitive impairment, as well as the challenges and ethical considerations that come with using AI to analyze something as personal as a person’s voice.
Cole, wearing sunglasses and a purple Calming the Storm t-shirt with a rainbow, is seated on a blanket outdoors and holding a Mott teddy bear.
Philanthropy News

A pediatric epilepsy fundraiser that changes lives

Your support of Calming the Storm advances pediatric epilepsy research and patient care programs. There are many ways you can contribute to make a difference for so many children and families.
Doctor performing a test
News Release

Michigan Alzheimer's Disease Research Center receives $22M to advance efforts statewide

NIH renews $22M for Michigan Alzheimer's Disease Research Center, supporting a first-of-its-kind statewide partnership and dementia research.